Nursing 2025-2026 drug handbook / Wolters Kluwer (COR)

Language: English Publisher: Philadelphia, PA, : Wolters Kluwer, 2024Description: xi, 1668 pages : illustrations (some color) ; 21 cmContent type: text | still image Media type: unmediated Carrier type: volumeISBN: 9781975217112; 197521711XSubject(s): Clinical pharmacology | Drugs -- Administration -- Handbooks, manuals, etcDDC classification: 615 Summary: "The #1 Drug Guide for nurses and clinicians... always dependable, always up to-date! Now in its 45th Edition, Nursing 2025-2026 Drug Handbook delivers the most current nursing focused information on more than 3,600 generic, brand-name, and combination drugs in an easy-to-use A-Z format. Features: NEW! Includes 24 brand-new FDA-approved drugs -- tabbed and conveniently grouped in a handy "NEW DRUGS" section for easy retrieval ; NEW! Thousands of clinical updates -- new dosages and indications, FDA boxed warnings, genetic-related information, adverse reactions, interactions, nursing considerations, clinical alerts, and patient teaching information ; Special focus on U.S. and Canadian drug safety issues and concerns.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Home library Call number Status Date due Barcode Item holds
BOOK BOOK COLLEGE LIBRARY
COLLEGE LIBRARY
GENERAL REFERENCE 		615 N9381 2024 (Browse shelf) Available
Total holds: 0

"The #1 Drug Guide for nurses and clinicians... always dependable, always up to-date! Now in its 45th Edition, Nursing 2025-2026 Drug Handbook delivers the most current nursing focused information on more than 3,600 generic, brand-name, and combination drugs in an easy-to-use A-Z format. Features: NEW! Includes 24 brand-new FDA-approved drugs -- tabbed and conveniently grouped in a handy "NEW DRUGS" section for easy retrieval ; NEW! Thousands of clinical updates -- new dosages and indications, FDA boxed warnings, genetic-related information, adverse reactions, interactions, nursing considerations, clinical alerts, and patient teaching information ; Special focus on U.S. and Canadian drug safety issues and concerns.

There are no comments for this item.

to post a comment.